Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-Specific T-Cell Adoptive Transfer [ERaDICATe]

		Phase:		Phase 1

		Treatment ID#:		1845

		Age Group:		Adults Only

		Min Karnofsky Score:		80: Able to perform normal activity with effort; some signs and symptoms of disease

		Conditions:		Prior Surgery is Sometimes Allowed Prior Radiation is Sometimes Allowed Prior Chemotherapy is Sometimes Allowed

		Last Updated:		03/02/2008

		Tumor Types:		Glioblastoma Multiforme


		Comments:		Click the link above for more details

		Treatment Type:		Immunological, Biological or Targeted Therapy

		Contact:		Henry Friedman MD The Brain Tumor Center at Duke Rm 047 Baker House, Hospital South Trent Drive Durham, NC 27710- USA Phone: (919)684-5301 Fax: (919)684-6674 E-mail: fried003@mc.duke.edu Website: www.cancer.duke.edu/btc

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By